Boston Scientific has disclosed a cybersecurity incident that caused a global disruption to its operations, knocking offline key information systems used to process and ship customer orders[1][3][9]. The medical device maker said the attack has led to a network outage affecting corporate IT and business applications across multiple regions[1][4][11].
The company identified the cyberattack on August 25 and activated its incident-response procedures, including engaging third-party cybersecurity specialists to investigate and contain the threat[1][3][4]. In a filing with the U.S. Securities and Exchange Commission, Boston Scientific reported that the incident has restricted or disrupted access to certain information systems and applications that support critical aspects of its operations, including order processing and logistics[3][9][11]. The company is working to restore affected systems but has not provided a timeline for full recovery and has yet to determine whether the incident is reasonably likely to have a material impact on its financial results[4][9][11].
The operational fallout has been felt across Boston Scientific’s global footprint, with disruptions to the processing and shipping of customer orders for its medical devices[1][3][5]. While core manufacturing has not been publicly described as shut down, the loss of normal IT and business-application access has complicated routine fulfillment and may force customers to adjust inventory plans in the short term[3][5][11]. Shares of Boston Scientific fell following the disclosure, with multiple financial outlets reporting an intraday decline of around 3% as investors reacted to the outage and ongoing uncertainty around its duration and impact[2][6][9].
Boston Scientific has not disclosed the root cause of the breach, whether ransomware is involved, or if any personal or patient data was accessed[4][7]. Media reports note that the company has not said how attackers gained access to its environment and that, as of August 27, no threat group has publicly claimed responsibility for the incident[1][7][13]. The company’s public statements describe the attack as affecting “certain information technology systems” but do not indicate any direct impact on implanted medical devices or the safety or performance of products used in patient care[4][7][11].
The company has a history of publishing product-security notices around major third-party vulnerabilities, including statements on the Progress MOVEit Transfer flaws and the Apache Log4j remote code execution bug, in which it reported no use of vulnerable MOVEit components in its devices and assessed limited exposure to Log4j in its product portfolio[12][14][15]. Those earlier bulletins underscore Boston Scientific’s broader vulnerability-management efforts but are separate from the current enterprise IT intrusion, which appears to be focused on back-office and operational systems rather than device firmware or clinical systems[4][12][14].
For hospitals, distributors, and other healthcare providers that rely on Boston Scientific’s devices, the incident highlights the operational risk posed by cyberattacks on upstream manufacturers, even when clinical products remain unaffected[3][6][11]. Security leaders in healthcare and life sciences may want to review business-continuity plans for critical-device supply, validate safety stocks, and ensure they receive timely communications from the vendor about order status and system restoration milestones, while monitoring for any subsequent disclosures about data exposure or regulatory findings related to the breach.
References
- Boston Scientific hit by cyberattack, global operations affected
- Medical device maker Boston Scientific is being hit by a cyberattack. The shares are falling
- Boston Scientific says cyberattack disrupted order processing …
- Update on recent cybersecurity incident
- Boston Scientific Says Cyberattack Disrupting Global Operations
- Boston Scientific Stock Price Drops After Cyberattack Triggers Global Outage
- Cyberattack Disrupts Boston Scientific’s Operations: 7 Things to Know
- Boston Scientific Stock Slides After Cyberattack Caused ‘ …
- Boston Scientific says cyberattack disrupted order …
- CISA:CVE-2024-5805 AND CVE- …
- Boston Scientific shares fall after cybersecurity incident disrupts …
- Boston Scien�fic Public – Public Release Authorized
- Boston Scientific Public – Public Release Authorized
